Peptide library › Heart & blood
Pegcetacoplan
Also known as Empaveli, Syfovre, Aspaveli
Complement blocker used for the rare blood disease PNH (as an infusion under the skin) and for geographic atrophy in the eye (as an eye injection).
What people use it for
- Paroxysmal nocturnal haemoglobinuria (PNH)
- Geographic atrophy from age-related macular degeneration (eye injection)
- Some complement-driven kidney diseases
What Pegcetacoplan does in the body
A ring-shaped peptide attached to PEG that blocks complement C3, a central part of the immune system's complement cascade, which destroys red blood cells in PNH and damages the retina in geographic atrophy.
Strength of evidence
Strong: Phase 3 trials (PEGASUS in PNH; OAKS and DERBY in geographic atrophy).
Look up the evidence
- Reviews on PubMed: Summaries of the published research
- Clinical trials on PubMed: Published studies in people
- ClinicalTrials.gov: Registered trials, past and ongoing
- Prescribing information (DailyMed, US): Official US label
- Patient leaflets (emc, UK): Official UK product information
Live searches of official databases. New to the terms? See the glossary.
Reported side effects & risks
- Serious infections from encapsulated bacteria (Empaveli); vaccines are needed first
- Injection-site reactions
- Eye inflammation and other eye problems (Syfovre)
Who should avoid it or take extra care
- Unresolved serious bacterial infection
- Not up to date with required vaccines
- Eye infection (for the eye injection)
Not a complete list. Check with a doctor or pharmacist about your own health and medicines.
Regulatory status
FDA-approved as Empaveli (2021, PNH) and Syfovre (2023, eye). Empaveli carries a boxed warning for serious infections.
How it's taken
Route: Infusion under the skin twice weekly (Empaveli), or injection into the eye (Syfovre)
How long it lasts (half-life): About 8 days
Latest research & news
- Network Meta-Analysis of Complement Inhibitors for Geographic Atrophy in Age-Related Macular Degeneration
Research · Review · PubMed · Surv Ophthalmol · 19 Nov 2026 - Complement Inhibitors for C3 Glomerulopathy and Primary Immune Complex Membranoproliferative Glomerulonephritis: A Systematic Review and Bayesian Network Meta-Analysis
Research · Study · PubMed · Clin J Am Soc Nephrol · 18 Nov 2026 - Self-administered therapies in paroxysmal nocturnal hemoglobinuria: balancing quality of life with clinically relevant risks
Research · Study · PubMed · Expert Rev Hematol · 18 Nov 2026 - Early Utilization Patterns and Adverse Outcomes of Anti-Complement Therapy in Geographic Atrophy in the Clinical Setting
Research · Study · PubMed · Ophthalmol Retina · 16 Nov 2026
Picked automatically from PubMed, ClinicalTrials.gov and the FDA, and updated daily. Early, lab and animal studies often don't carry over to people.
Keep track of Pegcetacoplan privately
Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.
Open Pegcetacoplan in Fiala How to installMore in Heart & blood
- EnlicitideFirst daily tablet that blocks PCSK9 to lower LDL ("bad") cholesterol, a job that previously needed injections.
- Angiotensin IIIntensive-care drip that raises dangerously low blood pressure in shock when other drugs aren't enough.
- BivalirudinShort-acting blood thinner given by drip during heart procedures such as stenting.
- DesirudinLab-made leech-derived blood thinner once used to prevent clots after hip replacement; now discontinued in the US.
- EptifibatideHospital drip that stops platelets clumping during heart attacks and stenting.
- NesiritideLab-made heart hormone (BNP) once used by drip for sudden heart failure; now largely withdrawn.
- VasopressinNatural hormone given by drip in intensive care to raise blood pressure in shock.
- SelepressinExperimental vasopressin-like drug for septic shock that failed its main trial.
- DesmopressinSynthetic version of the water-retaining hormone, used for bedwetting, frequent night-time urination, diabetes insipidus and some bleeding disorders.
- TerlipressinHospital drug that improves kidney function in hepatorenal syndrome, a kidney failure caused by severe liver disease.
- RusfertideWeekly injection that mimics the iron hormone hepcidin to control red blood cell overproduction in polycythemia vera.